Viewing Study NCT01579461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-02-08 @ 6:50 AM
Study NCT ID: NCT01579461
Status: COMPLETED
Last Update Posted: 2013-09-05
First Post: 2012-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics View
None Healthy Subjects View
None Mild and Moderate Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacokinetics View
None mirabegron View
None hepatic impairment View
None Phase 1 View